Bio Saga Blog - A Chronicle of Life Sciences & Informatics

Biocon is an integrated biotechnology enterprise focused on the development of biopharmaceuticals. With successful initiatives in drug discovery and development, bioprocessing, manufacturing and global marketing, Biocon delivers products and solutions to partners and customers in over 75 countries. Biocon has the defining science, world class capabilities and a focused vision to deliver the promise of innovative and affordable medicine to a waiting world. Today, Biocon together with group companies employs more than 5000 employees with approxmimately Rs 2500 crore turnover and is expected to grow further during the current financial year. Post :  Area Business Manager Experience :  3-6 years No of openings :  Five Educational Qualification :  B.Sc Life Science, Biotechnoology | M.Sc Life Science, Biotechnology Job Description : Attain or exceed sales budgets quarter-wise. Ensure new prescriptions, customers / markets are generated. Ensure that the key marke...

Courtesy jobsinsciences.com Research Associate position Molecular Biology at Piramal Life Sciences Research Associate Piramal Life Sciences Ltd Experience: 1 – 2 Years Compensation:Rupees 2,00,000 – 2,25,000 Education: UG – B.Sc – Bio-Chemistry,B.Tech/B.E. – Bio-Chemistry/Bio-Technology PG – M.Sc – Bio-Chemistry,M.Tech – Bio-Chemistry/Bio-Technology Job Description • Responsible for performing research and development experiments for projects and products, in collaboration with others. • Regularly exercises technical discretion in the [...] Principal Investigator/ Senior Principal Investigator – Neuroscience at Syngene International Ltd Principal Investigator/Senior Principal Investigator for Neuroscience Syngene International Limited Experience: 5 – 10 Years Compensation:Rupees 6,00,000 – 9,00,000 Education:UG – Any Graduate – Any Specialization,Graduation Not Required PG – Any PG Course – Any Specialization,Post Graduation Not Required Job Description Qualification: Ph.D. in P...

Creating an alliance to deliver insulin treatments worldwide, Biocon and  Pfizer  have entered into a global commercialisation agreement. Pfizer will make an upfront payment of USD 200 million in a licensing deal for Biocon’s biosimilar insulin portfolio for diabetes treatment. As per the agreement,  Biocon  will also be eligible to get additional payments of up to USD 150 million. These payments will be linked to sales of Biocon’s insulin biosimilars. In an interview with CNBC-TV18, Vikas Dandekar of pharmasianews.com gave his perspective on the deal. Excerpts from  Reporter's Diary on CNBC-TV18 Watch the full show » Q: What do you make of this arrangement? First of all tell is what is the potential the market size as far as this insulin is concerned and what does this mean both for Biocon and Pfizer? A: A number of biosimilars are scheduled to be launched in the European market. A number of trials are going on, on insulin and this is a big potenti...

Various positions are open at Biocon-India currently (even for fresh graduates) Please go through this link: http://www.biocon.com/biocon_careers_job.asp Submit your resumes at careers@biocon.com Manager Sr Manager/Deputy General Manager - HR Senior Scientist - Process development cell culture-R&D Scientist / Sr. Scientist - RND - ANF Manager / Sr. Manager - Production Sr. Manager - Phamacovigilance Jr. Executive - Production Executive - Production Junior Executive Toxicology ...